Axios Pro: Biotech Deals delivers the latest VC, PE and M&A news across pharma, biotech, health tech and more.
Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...
Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues- Astellas to lead commercialization of VIR-5500 in the U.S. with Vir Biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results